Journal of Surgery Concepts & Practice >

2023 , Vol. 28 >Issue 05: 415 - 419

DOI: https://doi.org/10.16139/j.1007-9610.2023.05.04

Experts forum

The strategy of extrahepatic organs management in early period after adult liver transplantation

Expand
  • Department of Critical Care Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China

Received date: 2023-08-23

  Online published: 2024-01-04

Fold

Abstract

With the improvements in surgical technique, the indications for liver transplantation(LT) are being expanded to more complex and severe patients, who not only have liver function in the terminal stage, but also extrahepatic organs involve of varying degrees dysfunction. It was demonstrated that the strategy of extrahepatic organs management in early period after LT was associated with improving recovery. This paper summarized the strategy of extrahepatic organs management in early period after adult LT. Continuing to monitor system hemodynamics is helpful for stable graft perfusion. It is necessary to manage derangements of preload, myocardial contractility, and afterload. Early postoperative extubation is recommended by current guidelines. Routine screening pulmonary complications may help weaning from the ventilator. The diagnosis of acute kidney injury(AKI) after LT has been reported to using Kidney Disease: Improving Global Outcomes(KDIGO) criteria, a delayed calcineurin inhibitor initiation strategy may be beneficial for renal protection. Currently, there is no consensus on timing of renal replacement therapy initiation in patients with AKI. Patients with cirrhosis and a history of hepatic encephalopathy(HE) displays impaired neurological recovery, the diagnosis of HE is crucial and challenging.

Key words： Liver transplantation; Extrahepatic organ; Intensive care

Cite this article

DENG Yuxiao, ZHAO Xianyuan, GAO Yuan . The strategy of extrahepatic organs management in early period after adult liver transplantation[J]. Journal of Surgery Concepts & Practice, 2023 , 28(05) : 415 -419 . DOI: 10.16139/j.1007-9610.2023.05.04

References

[1] JOSEPH D, MINNA K, MICHAEL P, et al. Damage control as a strategy to manage postreperfusion hemodynamic instability and coagulopathy in liver transplant[J]. JAMA Surg, 2015, 150(11):1066-1072.
[2] OMAR A, MOHAMMAD K, VENKATESWARAN C, et al. An evaluation of the safety and preliminary efficacy of peri- and post-operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients[J]. Clin Transplant, 2021, 35(6):e14298.
[3] IZZY M, VANWAGNER L, LIN G, et al. Redefifining cirrhotic cardiomyopathy for the modern era[J]. Hepatology, 2020, 71(1):334-345.
[4] XINGXING S, LISA B, SALVATORE P, et al. Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates: a scientific statement from the american heart association: endorsed by the American Society of Transplantation[J]. Circulation, 2022, 146(21):e299-e324.
[5] KRISTA L, SALVATORE P, MATTHEW R, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation[J]. J Am Coll Cardiol, 2012, 60(5):434-480.
[6] MARC H, GABOR K, MARIUS M, et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Respir J,2023, 61(1):2200879.
[7] AMRIN K, ISRAEL S, ADEBOLU O, et al. Incidence, predictors and outcomes of new onset systolic heart fai-lure following orthotopic liver transplant: a systematic review[J]. Transplant Rev (Orlando), 2023, 37(2):100758.
[8] LI Z, DING C, DENG Y, et al. Bedside electrical impe-dance tomography (EIT) for early assessment of lung function in liver transplantation[J]. QJM, 2023,hcad174.
[9] WOJCIECH F, GRZEGORZ N, MICHA? G, et al. Postoperative supplemental oxygen in liver transplantation (PSOLT) does not reduce the rate of infections: results of a randomized controlled trial[J]. BMC Med, 2023, 21(1):51.
[10] RAFFAELE B, ANTOINE M, STEFANO S, et al. Guidelines for perioperative care for liver transplantation: enhanced recovery after surgery (ERAS) recommendations[J]. Transplantation, 2022, 106(3):552-561.
[11] 李霄, 陶开山. 中国肝移植术后并发症诊疗规范(2019版)[J]. 中华移植杂志(电子版), 2019, 13(4):269-272.
[11] LI X, TAO K S. Diagnostic and therapeutic standardization of postoperative complications of liver transplantation in China[J]. Chin J Transplant (Electronic Edition), 2019, 13(4):269-272.
[12] BARRETO A, DAHER E, SILVA J, et al. Risk factors for acute kidney injury and 30-day mortality after liver transplantation[J]. Ann Hepatol, 2015, 14(5):688-694.
[13] MARK D, ANDREW D. Reading between the (guide)lines -the KDIGO practice guideline on acute kidney injury in the individual patient[J]. Kidney Int, 2014, 85(1):39-48.
[14] CABEZUELO J, RAMíREZ P, RíOS A, et al. Risk factors of acute renal failure after liver transplantation[J]. Kidney Int, 2006, 69(6):1073-1080.
[15] BARRETO R, ELIA C, SOLA E, et al. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections[J]. J Hepatol, 2014, 61(1):35-42.
[16] BELCHER J, GARCIA-TSAO G, SANYAL A, et al. Urinary biomarkers and progression of AKI in patients with cirrhosis[J]. Clin J Am Soc Nephrol, 2014, 9(11):1857-1867.
[17] CHEN C, CHEN X, ZHAO X, et al. Using postoperative coagulation parameters within 24 h after liver transplantation to predict incidence of stage 3 acute kidney injury (AKI)[J]. Ann Transplant, 2022, 27: e937535.
[18] HASHIM M, ALSEBAEY A, RAGAB A, et al. Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: a single center study[J]. Ann Hepatol, 2020, 19(5):541-545.
[19] SCHMEDING M, KIESSLING A, NEUHAUS R, et al. Mycophenolate mofetil monotherapy in liver transplantation: 5-year follow-up of a prospective randomized trial[J]. Transplantation, 2011, 92(8):923-929.
[20] HENDRIK V, PIERO A, JASMOHAN B, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver[J]. Hepatology, 2014, 60(2):715-735.
[21] EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER. EASL clinical practice guidelines on the management of hepatic encephalopathy[J]. J Hepatol, 2022, 77(3):807-824.
[22] ANNA-ELISABETH H, MEIKE D, CARLOTTA P, et al. Hepatic encephalopathy is reversible in the long term after liver transplantation[J]. Liver Transpl, 2019, 25(11):1661-1672.
[23] HORNG-REN Y, ASHOK T, LONG-BIN J, et al. Living donor liver transplantation in acute liver failure patients with grade Ⅳ encephalopathy: is deep hepatic coma still an absolute contraindication? A successful single-center experience[J]. Ann Transplant, 2018, 23:176-181.
[24] KHALID M B, NAGORNA A, RIPPEL N, et al. Early neurologic complications post liver transplant are associa-ted with reduced long-term survival and increased rates of rejection[J]. Liver Transpl, 2023, 29(10):1079-1088.
Options
Outlines

/

〈 〉